Anzeigenschluss: 27.09.2024
Erscheinungstermin: 24.10.2024
Krebs und Diabetes
Editorial
H. Adamek
Aufgefallen
I. Sonntag, H. Adamek
Hyperglykämierisiko unter Thyrosin-Kinase-Therapie
Journal Club
K. Müssig
A. Sabag, M. N. Amadi, M. E. Francois: Timing of Moderate to Vigorous Physical Activity, Mortality, Cardiovascular Disease, and Microvascular Disease in Adults with Obesity
K. Müssig
L. G. Singh, S. Ntelis, T. Siddiqui: Association of Continued Use of SGLT2 Inhibitors from the Ambulatory to Inpatient Setting with Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study
K. Müssig
B. V. Hagerf, M. Protus, L. Nemetova: Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation
N. Schloot
M. Auzanneau et al.: Diabetes care and outcomes of pediatric refugees and migrants from Ukraine and Syria/Afghanistan with type 1 diabetes in German- speaking countries
N. Schloot
T. Avdic et al.: Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study
E. Fritschka
V. Perkovic et al.: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
E. Fritschka
A. Rawshani et al.: Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study
K. Müssig
M. Spaur, M. Galvez- Fernandez, Q. Chen et al.: Association of Water Arsenic with Incident Diabetes in U.S. Adults: The Multi-Ethnic Study of Atherosclerosis and the Strong Heart Study
A. Thomas
L. Ang et al.: Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit
T. Kapellen
M. R. Rayas et al.: Association of race and ethnicity with the development of cystic fibrosis-related diabetes
T. Kapellen
C. Baechle et al.: Trends in the incidence of type 1 diabetes and type 2 diabetes in children and adolescents in North Rhine-Westphalia, Germany, from 2002 to 2022
Fortbildung
H. Scherübl
CME: Gastrointestinale Krebsvorsorge bei Patienten mit Typ 2-Diabetes
H. Adamek, K. Müssig
Diabetespatienten während der Koloskopie (-Vorbereitung): Was ist zu beachten?
aktuell
DZD: Prävention von Typ-2-Diabetes
*Die Redaktion behält sich aktuelle Änderungen vor.